Buy Byetta 250 ug/mL exenatide

Byetta 250 ug/mL is a subcutaneous injection containing exenatide, used for managing type 2 diabetes. This medication supports blood sugar control as part of a broader treatment plan.

Strength

250 ug/mL

Pack Size

1 CARTRIDGE in 1 CARTON (0310-6524-01) / 2.4 mL in 1 CARTRIDGE

Manufacturer / TM Owner

AstraZeneca Pharmaceuticals LP

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Byetta 250 ug/mL is primarily used to improve glycemic control in adults with type 2 diabetes. It is often prescribed alongside diet and exercise to help manage blood sugar levels. This medication works by mimicking natural hormones in the body to regulate glucose. People often ask, 'What is Byetta used for?' and the answer is that it is designed to assist in diabetes management.

Side Effects

Common effects of Byetta 250 ug/mL may include nausea, vomiting, diarrhea, or injection site reactions. Some users experience reduced appetite or weight loss. These effects vary and are not exhaustive; individual responses can differ.

Precautions & Warnings

Byetta 250 ug/mL should be handled with care, following medical guidance. It is important to store it properly and use it as directed. Always inform healthcare providers about any existing conditions or medications before starting this treatment.

Avoid Interactions

Byetta 250 ug/mL may interact with certain medications, including those that affect blood sugar or digestion. Alcohol and other substances might also influence its effects. It is advisable to discuss potential interactions with a healthcare professional.

References

Frequently Asked Questions

Byetta 250 ug/mL is used to help manage type 2 diabetes by improving blood sugar control when used with diet and exercise.

Byetta 250 ug/mL is administered via subcutaneous injection, typically in the abdomen, thigh, or upper arm.

Common side effects may include nausea, vomiting, diarrhea, and injection site reactions.

Byetta 250 ug/mL may be used with other diabetes medications, but it is important to consult a healthcare provider to avoid potential interactions.

Byetta 250 ug/mL should be stored in the refrigerator between 36°F to 46°F (2°C to 8°C) and protected from light.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.